Andrew Spillane is a medical oncologist and professor at the University of Sydney. He is based at the Crows Nest Clinic in Sydney, Australia, where he provides clinical care and conducts research into the diagnosis and treatment of cancer. He has a particular interest in the use of targeted therapies, immunotherapies and novel agents for the treatment of lung cancer, melanoma and other solid tumours. He is also involved in the development of new clinical trials and the translation of research findings into clinical practice.